We focused on ADAT2, CCNL2, DBF4B, and TRIM45 mRNAs that played key roles in cancer biology to demonstrate that alteration of their translational efficiency occurred via a BRCA1-dependent mechanism in cultured cells and in patient tumors. Here, CCNL2 is linked to cancer.